Cipher Pharmaceuticals (CPHRF) News Today $10.29 +0.59 (+6.08%) (As of 11/18/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Stifel Nicolaus Remains a Buy on Cipher Pharmaceuticals (CPHRF)November 11, 2024 | markets.businessinsider.comCipher Pharmaceuticals Q3 2024 Results: Growth and AcquisitionsNovember 9, 2024 | markets.businessinsider.comCipher Pharmaceuticals Enhances Leadership Team with Appointment of New Chief Business OfficerOctober 8, 2024 | finance.yahoo.comStifel Nicolaus Sticks to Its Buy Rating for Cipher Pharmaceuticals (CPHRF)September 17, 2024 | markets.businessinsider.comCipher Pharmaceuticals Hit By Partner's Disappointing Trial DataSeptember 13, 2024 | marketwatch.comCipher Pharmaceuticals Partner Moberg Pharma AB Provides Update on MOB-015 Phase 3 StudySeptember 13, 2024 | finance.yahoo.comCipher Pharmaceuticals Inc (CPHRF)August 14, 2024 | investing.comCipher Pharmaceuticals Acquires Rights, Operations for Dermatological Treatment NatrobaJuly 29, 2024 | marketwatch.comCipher Pharmaceuticals acquires rights to dermatology productsJuly 29, 2024 | msn.comCipher Pharmaceuticals Acquires Profitable Growth Dermatology Products from ParaPRO for US$89.5 MillionJuly 29, 2024 | finance.yahoo.comCipher Pharmaceuticals First Quarter 2024 Earnings: Beats ExpectationsMay 11, 2024 | finance.yahoo.comCipher Pharmaceuticals Reports First Quarter 2024 ResultsMay 9, 2024 | finance.yahoo.comCipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference CallMay 3, 2024 | finance.yahoo.comCipher Pharmaceuticals Inc.'s (TSE:CPH) Stock's On An Uptrend: Are Strong Financials Guiding The Market?April 26, 2024 | finance.yahoo.comCipher Pharmaceuticals Inc.March 19, 2024 | wsj.comCipher Pharmaceuticals' (TSE:CPH) three-year earnings growth trails the 93% YoY shareholder returnsMarch 16, 2024 | finance.yahoo.comCipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 ResultsMarch 14, 2024 | finance.yahoo.comCipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference CallMarch 8, 2024 | finance.yahoo.comIs Cipher Stock (CPHRF) a Good Buy?February 17, 2024 | benzinga.comWill Uplisting Be the Catalyst to Send Sharesof this Pharma Company Higher?January 29, 2024 | msn.comOTC Markets Group Welcomes Cipher Pharmaceuticals Inc. to OTCQXJanuary 29, 2024 | finance.yahoo.comCipher Pharmaceuticals Inc. (CPH.TO)November 16, 2023 | ca.finance.yahoo.comCipher Pharmaceuticals Reports Strong Sales & Earnings Growth in Q3 2023November 9, 2023 | finance.yahoo.comCipher Pharmaceuticals Announces Final Results of Substantial Issuer BidOctober 12, 2023 | finance.yahoo.comCipher Pharmaceuticals Provides Reminder of the Upcoming Expiration of its Substantial Issuer BidOctober 3, 2023 | finance.yahoo.comCipher Pharmaceuticals (CPHRF) Receives a Buy from Stifel NicolausJune 1, 2023 | markets.businessinsider.comClosing Bell: Cipher Pharmaceuticals Inc up on Wednesday (CPH)May 17, 2023 | theglobeandmail.comCipher Pharmaceuticals GAAP EPS of $0.10 beats by $0.02, revenue of $4.9M misses by $0.64MMay 11, 2023 | seekingalpha.comCipher Pharmaceuticals Reports First Quarter Results, Highlighted by Record Cash Per Share and Strong Financial FlexibilityMay 11, 2023 | finance.yahoo.comClosing Bell: Cipher Pharmaceuticals Inc down on Tuesday (CPH)May 2, 2023 | theglobeandmail.comClosing Bell: Cipher Pharmaceuticals Inc up on Monday (CPH)May 2, 2023 | theglobeandmail.comClosing Bell: Cipher Pharmaceuticals Inc down on Thursday (CPH)April 27, 2023 | theglobeandmail.comClosing Bell: Cipher Pharmaceuticals Inc down on Friday (CPH)April 21, 2023 | theglobeandmail.comClosing Bell: Cipher Pharmaceuticals Inc up on Thursday (CPH)April 7, 2023 | theglobeandmail.comCipher Pharmaceuticals Inc. (CPHRF) Q4 2022 Earnings Call TranscriptMarch 20, 2023 | seekingalpha.comCipher Pharmaceuticals earnings: here's what Wall Street expectsMarch 17, 2023 | markets.businessinsider.comCipher Pharmaceuticals Schedules Q4 2022 Earnings Release and Conference CallMarch 10, 2023 | finance.yahoo.comCipher Pharmaceuticals (TSE:CPH) shareholders have earned a 51% CAGR over the last three yearsJanuary 31, 2023 | finance.yahoo.comCypher Core, Inc: CIPHER-CORE, Inc. President Addresses Company's Business DirectionJanuary 13, 2023 | finanznachrichten.deCipher Pharmaceuticals Inc. (CPHRF)November 11, 2022 | ca.finance.yahoo.comCipher Pharmaceuticals Reports Strong Third Quarter Results, Highlighted by USD$1.09 in Cash Per ShareNovember 10, 2022 | finance.yahoo.comInvesting in Cipher Pharmaceuticals (TSE:CPH) three years ago would have delivered you a 107% gainAugust 24, 2022 | finance.yahoo.comCipher Pharmaceuticals Inc. (CPHRF) CEO Craig Mull on Q2 2022 Results - Earnings Call TranscriptAugust 12, 2022 | seekingalpha.comCipher Pharmaceuticals Strengthens Leadership Team with Appointment of New CFOAugust 11, 2022 | finance.yahoo.comCipher Pharmaceuticals Inc stock boosted on Friday.July 9, 2022 | theglobeandmail.comCipher Pharmaceuticals GAAP EPS of C$0.08, revenue of C$5.4MMay 14, 2022 | seekingalpha.comIs Now The Time To Put Cipher Pharmaceuticals (TSE:CPH) On Your Watchlist?March 24, 2022 | finance.yahoo.comCipher Pharmaceuticals Announces Partner, Moberg Pharma's Regulatory Submission to FDA for North American Phase 3 StudyMarch 22, 2022 | finance.yahoo.comMariMed Doubles Full Year Revenue And Adjusted EBITDA, Reports Q4 & Full Year EarningsMarch 18, 2022 | benzinga.comMarijuana Stock Movers For March 16, 2022March 18, 2022 | msn.com Get Cipher Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPHRF and its competitors with MarketBeat's FREE daily newsletter. Email Address Free Cheat Sheet: Build a Dividend Portfolio (Ad)Have you ever wanted to build your own, custom dividend portfolio? A well-rounded portfolio of high quality dividend stocks that produce passive cash flow is one of the best ways to build your nest egg. And, according to one expert, you can do it with a very straightforward process too! These FIVE (FREE) Dividend Investing Cheatsheets Show you How! CPHRF Media Mentions By Week CPHRF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CPHRF News Sentiment▼0.500.57▲Average Medical News Sentiment CPHRF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CPHRF Articles This Week▼10▲CPHRF Articles Average Week Get Cipher Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPHRF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TGIFF News FFNTF News ABSCF News ACRHF News ACRDF News LBTSF News AZFL News ERBB News AWWH News AVTBF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CPHRF) was last updated on 11/18/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredThe Stock Powering Musk’s AI Revolution—RevealedImagine being able to invest in Tesla, PayPal, or SpaceX before the world knew their potential. Today, you ...InvestorPlace | SponsoredTrump’s EPIC Stock Market RallyPutting HUGE gain chances in the hands of hardworking, patriotic Americans like YOU. In fact, according to ...Paradigm Press | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cipher Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cipher Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CPHRF Stock Alerts